以腦部生物學為焦點的檢測

Mindful Care, a hybrid mental health provider offering both urgent care and ongoing therapy, has entered into a partnership with the precision psychiatry company NeuroKaire to integrate a novel biological test into its standard clinical practice. This service will be known as the BrightKaire test.

The collaboration between Mindful Care and NeuroKaire marks a significant shift in how antidepressant medications are selected, moving away from the traditional trial-and-error method towards a process informed by an individual patient's unique cellular biology. The core of this innovation is a simple blood draw that is used to create a personalized model of a patient's brain cells, specifically frontal cortex neurons, which are then exposed to a range of common antidepressants to observe their real-time reactions. This scientific approach, which leverages Nobel Prize-winning stem cell technology, allows clinicians to see, in effect, how a patient’s own brain tissue would respond to various drugs before any medication is actually taken.